Grimal ophthalmic solution

Grimal is an ophthalmic solution containing Sodium Hyaluronate and Oxymetazoline, used primarily for eye relief and lubrication. It is produced by Laboratorios Grin, a specialized pharmaceutical company established in Mexico with over 60 years of history in the ophthalmic market.

In 2011, Laboratorios Grin was acquired by the Indian multinational pharmaceutical giant Lupin Limited. This acquisition integrated the Mexican brand into a global network. Today, while the brand maintains its Mexican heritage and local manufacturing presence, it is ultimately owned and managed by Lupin, headquartered in Mumbai, India.